Guy E Thwaites Selected Research

Guy E Thwaites Research Topics

Disease

39	Meningeal Tuberculosis (Tuberculous Meningitis) 01/2024 - 10/2003
23	Tuberculosis (Tuberculoses) 05/2024 - 03/2004
21	Infections 01/2022 - 07/2005
10	Typhoid Fever (Typhoid) 12/2020 - 01/2008
7	Inflammation (Inflammations) 01/2022 - 07/2005
6	Malaria 01/2020 - 12/2015
4	Cryptococcal Meningitis 01/2021 - 10/2016
3	Tetanus 01/2022 - 01/2018
3	Coma (Comas) 01/2017 - 07/2011
3	Bacterial Meningitis 01/2015 - 03/2010
2	Hepatitis C 01/2023 - 01/2019
2	Bacillary Dysentery (Shigellosis) 12/2021 - 01/2018
2	Sepsis (Septicemia) 12/2021 - 01/2018
2	Wounds and Injuries (Trauma) 12/2019 - 04/2016
2	Brain Infarction 11/2019 - 01/2018
2	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2019 - 12/2015
2	Ventilator-Associated Pneumonia 01/2018 - 01/2017
2	Chemical and Drug Induced Liver Injury 01/2018 - 01/2018
2	Infarction (Infarctions) 01/2018 - 03/2007
2	Diarrhea 01/2018 - 01/2018
2	Fever (Fevers) 06/2017 - 05/2016
2	HIV Infections (HIV Infection) 01/2017 - 10/2004
2	Body Weight (Weight, Body) 04/2016 - 01/2016
2	Meningitis 07/2008 - 09/2007
1	Liver Diseases (Liver Disease) 01/2023
1	Polyps 10/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Human Influenza (Influenza) 11/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Reinfection 12/2020
1	Vivax Malaria 01/2020
1	COVID-19 01/2020
1	Hemorrhage 12/2019
1	Communicable Diseases (Infectious Diseases) 10/2019
1	Breast Neoplasms (Breast Cancer) 09/2019
1	Mycoses (Diseases, Fungus) 01/2019

Drug/Important Bio-Agent (IBA)

17	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024 - 10/2004
11	Rifampin (Rifampicin)FDA LinkGeneric 05/2024 - 07/2005
10	Isoniazid (Ftivazide)FDA LinkGeneric 11/2023 - 03/2004
10	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2008
8	CytokinesIBA 11/2023 - 10/2003
6	FluoroquinolonesIBA 12/2021 - 07/2011
4	VaccinesIBA 12/2021 - 05/2016
4	leukotriene A4 hydrolaseIBA 01/2021 - 01/2017
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 10/2004
4	artemisinin (artemisinine)IBA 01/2019 - 12/2015
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2005
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2023 - 01/2018
3	Azithromycin (Zithromax)FDA LinkGeneric 12/2020 - 06/2017
3	AntigensIBA 10/2019 - 02/2014
3	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 06/2017 - 07/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023 - 01/2022
2	16S Ribosomal RNAIBA 10/2022 - 01/2018
2	InterferonsIBA 01/2022 - 01/2019
2	AntitoxinsIBA 01/2022 - 01/2018
2	AntibodiesIBA 11/2021 - 01/2019
2	Fluconazole (Zonal)FDA LinkGeneric 01/2021 - 09/2019
2	Tamoxifen FDA LinkGeneric 01/2021 - 09/2019
2	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2021 - 09/2019
2	SodiumIBA 01/2020 - 01/2018
2	LigandsIBA 01/2020 - 10/2019
2	artenimol (dihydroartemisinin)IBA 01/2019 - 11/2017
2	piperaquineIBA 01/2019 - 11/2017
2	Coloring Agents (Dyes)IBA 12/2018 - 02/2014
2	Methicillin (Metin)FDA Link 10/2018 - 01/2018
2	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 01/2018
2	Cephalosporins (Cephalosporin Antibiotics)IBA 11/2017 - 05/2016
2	Levofloxacin (Levaquin)FDA Link 09/2017 - 01/2016
2	Gatifloxacin (Zymar)FDA Link 06/2017 - 05/2016
2	LipidsIBA 01/2017 - 01/2011
2	EicosanoidsIBA 01/2017 - 02/2012
2	Glucose (Dextrose)FDA LinkGeneric 10/2016 - 09/2007
2	Conjugate VaccinesIBA 01/2016 - 07/2008
2	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2007 - 10/2006
1	GlucocorticoidsIBA 10/2023
1	daclatasvirIBA 01/2023
1	SofosbuvirIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Interleukin-12 (IL 12)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	ProteomeIBA 01/2022
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2021
1	8-aminoquinolineIBA 01/2020
1	Chloroquine (Aralen)FDA LinkGeneric 01/2020
1	Thromboxane A2 (A2, Thromboxane)IBA 11/2019

Therapy/Procedure

21	Therapeutics 01/2023 - 02/2012
4	Drug Therapy (Chemotherapy) 01/2019 - 03/2004
3	Catheters 01/2018 - 12/2010
2	Mechanical Ventilators (Ventilator) 01/2022 - 01/2017
2	Critical Care (Surgical Intensive Care) 01/2021 - 01/2019
2	Mass Drug Administration 01/2019 - 01/2019
2	Artificial Respiration (Mechanical Ventilation) 01/2018 - 01/2018
1	Retreatment 01/2023
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2023
1	Chemoprevention 01/2020
1	Personal Protective Equipment 12/2019
1	Duration of Therapy 01/2019
1	Injections 01/2019
1	Lasers (Laser) 01/2019